ORPHA:334
Hereditary atrial fibrillation
Publications
6
8th percentile
Trials
0
Interventional, condition-specific
Researchers
30
Distinct authors in sample
Gene link
—
Readiness
4/6
Stages with a signal
Clinical definition (Orphanet)
Familial atrial fibrillation is a rare, genetically heterogenous cardiac disease characterized by erratic activation of the atria with an irregular ventricular response, in various members of a single family. It may be asymptomatic or associated with palpitations, dyspnea and light-headedness. Concomitant rhythm disorders and cardiomyopathies are frequently reported.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0018054
- UMLS:C3468561
Additional Mondo synonyms (1)
hereditary atrial fibrillation (disease)
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
6 matched papers (1 in last 10 years) Source
- Phenotype characterisedPresent
77 HPO annotations (e.g. Left atrial enlargement; Atrial fibrillation; Atrial flutter) Source
- Animal modelPresent
1 genotype model (Mus musculus) Source
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPartial
None under the specific name; 2538 for broader category atrial fibrillation
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
77
Associated phenotypes · MONDO:0018054
- Left atrial enlargement
- Atrial fibrillation
- Atrial flutter
- Sudden cardiac death
- Supraventricular tachycardia
Showing 5 of 77 — open Monarch for the full list.
Animal models (Monarch / Alliance)
1
Model associations linked to this Mondo ID
- Tg(Myh6-rtTA)8585Jam/0 Tg(Myh6*/tetO-SCN5A*F1759A)#Marx/0 [background:] involves: C57BL/6 * CBA * FVB/NTac·MGI:5800485·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
6
6 papers have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
6 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
1 in the last 10 years · high confidence · 8th percentile (publications denominator)
Phrase hits: 6 · MeSH hits: 0
Who's working on it?
30
Distinct author names in 6 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Ackerman MJ1 paper · 2020
Department of Cardiovascular Medicine/Division of Heart Rhythm Services, Mayo Clinic, Rochester, MN, USA.
Papers in Europe PMC - 02Antzelevitch C1 paper · 2020
Lankenau Institute for Medical Research and Lankenau Heart Institute, Wynnewood, PA, USA.
Papers in Europe PMC - 03Ballew JD1 paper · 2008Papers in Europe PMC
- 04Bezzina CR1 paper · 2020
European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARD-HEART), Bruxelles, Belgium.
Papers in Europe PMC - 05Borggrefe M1 paper · 2020
1st Department of Medicine, University Medical Center Mannheim, Mannheim, Germany.
Papers in Europe PMC - 06Burnett JC Jr1 paper · 2008Papers in Europe PMC
- 07Cuneo BF1 paper · 2020
Department of Pediatrics, Division of Cardiology, Children's Hospital Colorado, Aurora, CO, USA.
Papers in Europe PMC - 08Darbar D1 paper · 2008Papers in Europe PMC
- 09de Andrade M1 paper · 2008Papers in Europe PMC
- 10Dekker LR1 paper · 2003Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 2,538 trials are registered for atrial fibrillation, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
high confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
2,538 interventional trials matched atrial fibrillation, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: atrial fibrillation
2,538
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07811934·NOT YET RECRUITING·Single-Use Spherical Pulsed Ablation Catheter for Paroxysmal Atrial Fibrillation
Conditions: Atrial Fibrillation (AF)·Matched via name phrase
- NCT06108414·RECRUITING·Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
Conditions: Atrial Fibrillation · Anticoagulant Adverse Reaction · Stroke · Major Adverse Cardiac Events·Matched via name phrase
- NCT06775028·RECRUITING·Integrated Approach in Frail Older People with Atrial Fibrillation
Conditions: Atrial Fibrillation (AF) · Hypertension · Coronary Arterial Disease (CAD) · Heart Failure·Matched via name phrase
- NCT06739512·NOT YET RECRUITING·Pulsed Field Ablation in Three Different Substrate Ablation Strategies for Persistent Atrial Fibrillation
Conditions: Atrial Fibrillation (AF)·Matched via name phrase
- NCT06715449·RECRUITING·EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source
Conditions: Embolic Stroke of Undetermined Source · Atrial Fibrillation New Onset·Matched via name phrase
- NCT07611019·ENROLLING BY INVITATION·Colchicine for the Prevention of Post-Operative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Single-Center, Strategy-Stratified, Randomized, Double-Blind, Placebo-Controlled Trial
Conditions: Post-Operative Atrial Fibrillation After Coronary Artery Bypass Grafting (CABG)·Matched via name phrase
- NCT01422148·NOT YET RECRUITING·Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery
Conditions: Atrial Fibrillation·Matched via name phrase
- NCT07444320·RECRUITING·Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System
Conditions: Paroxysmal Atrial Fibrillation · Persistent Atrial Fibrillation·Matched via name phrase
- NCT05511389·RECRUITING·Anteroposterior Versus Anterolateral Electrode Position for Electrical Cardioversion of Atrial Fibrillation
Conditions: Atrial Fibrillation · Atrial Flutter·Matched via name phrase
- NCT06096246·RECRUITING·Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)
Conditions: Persistent Atrial Fibrillation · Cardiac Arrhythmia · Catheter Ablation·Matched via name phrase
- NCT07278089·RECRUITING·AF Screening in Patients With Abnormal Echocardiographic Parameters
Conditions: Atrial Fibrillation (AF)·Matched via name phrase
- NCT07410962·NOT YET RECRUITING·Safety and Initial Efficacy Study of a Cardiac Surgical Pulsed Field Ablation System for the Treatment of Atrial Fibrillation
Conditions: Atrial Fibrillation Fluttering·Matched via name phrase
- NCT04796714·RECRUITING·AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE
Conditions: Atrial Fibrillation · Atrial Appendage · Anticoagulants · Stroke·Matched via name phrase
- NCT05115214·RECRUITING·Safety and Performance of the Affera SpherePVI™ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation
Conditions: Atrial Fibrillation·Matched via name phrase
- NCT06927908·NOT YET RECRUITING·Cardiac Denervation in Aortic Arch Replacement
Conditions: Atrial Fibrillation (AF) · Aortic Arch Replacement·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 7 · after dedupe 7 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 7 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (7)
- isrctn·ISRCTN84539143·Recruiting·LACunar Intervention trial - Cognition 1
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN49320109·Recruiting·A CAR T trial for amyloid light chain amyloidosis (AL Amyloid)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN34217298·No longer recruiting·Clinical trial of the non-surgical management of radiotherapy damage to the lower jaw
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12885480·Recruiting·Ruxolitinib versus hydroxycarbamide or interferon as first-line therapy in high-risk polcythemia vera
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN41847489·No longer recruiting·PrImary Care management for optimized ANtithrombotic Treatment
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN74381875·Stopped·Percutaneous Randomised Infusion of Marrow Aspirate To Improve Ventricular Efficiency
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN53177482·No longer recruiting·Pioglitazone Influence of triglyceRide Accumulation in the Myocardium In Diabetes
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Hereditary atrial fibrillation — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Hereditary atrial fibrillation" OR "hereditary atrial fibrillation (disease)"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Hereditary atrial fibrillation" OR "hereditary atrial fibrillation (disease)"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"atrial fibrillation"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T13:27:42.962Z
